Jeffrey S. Hackman - Net Worth and Insider Trading

Jeffrey S. Hackman Net Worth

The estimated net worth of Jeffrey S. Hackman is at least $130,960 dollars as of 2025-07-24. Jeffrey S. Hackman is the CEO of Fennec Pharmaceuticals Inc and owns about 15,000 shares of Fennec Pharmaceuticals Inc (FENC) stock worth over $130,950. Jeffrey S. Hackman is also the See Remarks of Comera Life Sciences Holdings Inc and owns about 47,600 shares of Comera Life Sciences Holdings Inc (CMRA) stock worth over $10. Details can be seen in Jeffrey S. Hackman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey S. Hackman has not made any transactions after 2025-05-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Jeffrey S. Hackman

To

Jeffrey S. Hackman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey S. Hackman owns 1 companies in total, including Comera Life Sciences Holdings Inc (CMRA) .

Click here to see the complete history of Jeffrey S. Hackman’s form 4 insider trades.

Insider Ownership Summary of Jeffrey S. Hackman

Ticker Company Transaction Date Type of Owner
CMRA Comera Life Sciences Holdings Inc 2022-09-09 director & See Remarks

Jeffrey S. Hackman Latest Holdings Summary

Jeffrey S. Hackman currently owns a total of 2 stocks. Among these stocks, Jeffrey S. Hackman owns 15,000 shares of Fennec Pharmaceuticals Inc (FENC) as of May 19, 2025, with a value of $130,950 and a weighting of 99.99%. Jeffrey S. Hackman also owns 47,600 shares of Comera Life Sciences Holdings Inc (CMRA) as of September 9, 2022, with a value of $10 and a weighting of 0.01%.

Latest Holdings of Jeffrey S. Hackman

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FENC Fennec Pharmaceuticals Inc 2025-05-19 15,000 8.73 130,950
CMRA Comera Life Sciences Holdings Inc 2022-09-09 47,600 0.00 10

Holding Weightings of Jeffrey S. Hackman


Jeffrey S. Hackman Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey S. Hackman has made a total of 1 transactions in Fennec Pharmaceuticals Inc (FENC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fennec Pharmaceuticals Inc is the acquisition of 15,000 shares on May 19, 2025, which cost Jeffrey S. Hackman around $104,550.

According to the SEC Form 4 filings, Jeffrey S. Hackman has made a total of 1 transactions in Comera Life Sciences Holdings Inc (CMRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Comera Life Sciences Holdings Inc is the acquisition of 47,600 shares on September 9, 2022, which cost Jeffrey S. Hackman around $98,056.

Insider Trading History of Jeffrey S. Hackman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey S. Hackman Trading Performance

GuruFocus tracks the stock performance after each of Jeffrey S. Hackman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey S. Hackman is -30.2%. GuruFocus also compares Jeffrey S. Hackman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey S. Hackman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeffrey S. Hackman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeffrey S. Hackman

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.05 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.94 LIMIT LIMIT LIMIT LIMIT LIMIT

Jeffrey S. Hackman Ownership Network

Ownership Network List of Jeffrey S. Hackman

No Data

Ownership Network Relation of Jeffrey S. Hackman

Insider Network Chart


Jeffrey S. Hackman Owned Company Details

What does Comera Life Sciences Holdings Inc do?

Who are the key executives at Comera Life Sciences Holdings Inc?

Jeffrey S. Hackman is the director & See Remarks of Comera Life Sciences Holdings Inc. Other key executives at Comera Life Sciences Holdings Inc include Chief Financial Officer Michael Gerard Campbell , 10 percent owner Charles Cherington , and 10 percent owner David Soane .

Comera Life Sciences Holdings Inc (CMRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Comera Life Sciences Holdings Inc (CMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Comera Life Sciences Holdings Inc (CMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Comera Life Sciences Holdings Inc (CMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Comera Life Sciences Holdings Inc Insider Transactions

No Available Data

Jeffrey S. Hackman Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey S. Hackman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jeffrey S. Hackman's mailing address is: Woburn Ma 01801.